-
1
-
-
3142742254
-
-
and references cited therein. For a detailed discussion on the tautomerism of pyrazolones, see: a
-
For a detailed discussion on the tautomerism of pyrazolones, see: (a) Holzer, W.; Kautsch, C.; Laggner, C.; Claramunt, R. M.; Pérez-Torralba, M.; Alkorta, I.; Elguero, J. Tetrahedron 2004, 60, 6791; and references cited therein.
-
(2004)
Tetrahedron
, vol.60
, pp. 6791
-
-
Holzer, W.1
Kautsch, C.2
Laggner, C.3
Claramunt, R.M.4
Pérez-Torralba, M.5
Alkorta, I.6
Elguero, J.7
-
3
-
-
0001557370
-
-
For the synthesis of 4-acyl/carboxyl pyrazolones, see: a
-
For the synthesis of 4-acyl/carboxyl pyrazolones, see: (a) Jensen, B. S. Acta Chem. Scand. 1959, 13, 1668.
-
(1959)
Acta Chem. Scand
, vol.13
, pp. 1668
-
-
Jensen, B.S.1
-
4
-
-
84993911722
-
-
(b) Lopez, R.; León, G.; Oliva, A. J. Heterocycl. Chem. 1995, 32, 1377.
-
(1995)
J. Heterocycl. Chem
, vol.32
, pp. 1377
-
-
Lopez, R.1
León, G.2
Oliva, A.3
-
5
-
-
42949158398
-
-
For examples of reactions at C-4, see: (a) Bromination/nitration: Das, S, Mittra, A. S. J. Indian Chem. Soc. 1978, 55, 520
-
For examples of reactions at C-4, see: (a) Bromination/nitration: Das, S.; Mittra, A. S. J. Indian Chem. Soc. 1978, 55, 520.
-
-
-
-
6
-
-
0142026605
-
-
Azirine formation: Holzer, W.; Claramunt, R. M.; Pérez- Torralba, M.; Guggi, D.; Brehmer, T. H. J. Org. Chem. 2003, 68, 7943.
-
(b) Azirine formation: Holzer, W.; Claramunt, R. M.; Pérez- Torralba, M.; Guggi, D.; Brehmer, T. H. J. Org. Chem. 2003, 68, 7943.
-
-
-
-
7
-
-
0013483514
-
-
(a) Holzer, W.; Plagens, B.; Lorenz, K. Heterocycles 1997, 45, 309.
-
(1997)
Heterocycles
, vol.45
, pp. 309
-
-
Holzer, W.1
Plagens, B.2
Lorenz, K.3
-
8
-
-
2442447068
-
-
(b) Subasinghe, N. L.; Ali, F.; Illig, C. R.; Rudolph, M. J.; Lein, S.; Khalil, E.; Soll, R. M.; Bone, R. F.; Spurlino, J. C.; Des Jarlais, R. L.; Crysler, C. S.; Cummings, M. D.; Morris, P. E. Jr.; Kilpatrick, J. M.; Babu, Y. S. Bioorg. Med. Chem. Lett. 2004, 14, 3043.
-
(2004)
Bioorg. Med. Chem. Lett
, vol.14
, pp. 3043
-
-
Subasinghe, N.L.1
Ali, F.2
Illig, C.R.3
Rudolph, M.J.4
Lein, S.5
Khalil, E.6
Soll, R.M.7
Bone, R.F.8
Spurlino, J.C.9
Des Jarlais, R.L.10
Crysler, C.S.11
Cummings, M.D.12
Morris Jr., P.E.13
Kilpatrick, J.M.14
Babu, Y.S.15
-
9
-
-
84998389276
-
-
1H NMR chemical shifts: (a) Ogawa, K.; Terada, T.; Honna, T. Chem. Pharm. Bull. 1984, 32, 930.
-
1H NMR chemical shifts: (a) Ogawa, K.; Terada, T.; Honna, T. Chem. Pharm. Bull. 1984, 32, 930.
-
-
-
-
10
-
-
0008801891
-
-
(b) Bregant, N.; Perina, I.; Malnar, M. Croat. Chim. Acta 1977, 49, 813.
-
(1977)
Croat. Chim. Acta
, vol.49
, pp. 813
-
-
Bregant, N.1
Perina, I.2
Malnar, M.3
-
11
-
-
0029780656
-
-
and references cited therein
-
(a) Holzer, W.; Plagens, B. Sci. Pharm. 1996, 64, 455; and references cited therein.
-
(1996)
Sci. Pharm
, vol.64
, pp. 455
-
-
Holzer, W.1
Plagens, B.2
-
13
-
-
42949161192
-
-
(a) Terebenina, A.; Dimitrova, K.; Iordanov, B.; Chervenakov, P.; Borisov, G. Izv. Khim. 1985, 18, 31;
-
(1985)
Izv. Khim
, vol.18
, pp. 31
-
-
Terebenina, A.1
Dimitrova, K.2
Iordanov, B.3
Chervenakov, P.4
Borisov, G.5
-
14
-
-
42949167397
-
-
Chem. Abstr. 1986, 104, 148787.
-
(1986)
Chem. Abstr
, vol.104
, pp. 148787
-
-
-
15
-
-
42949157406
-
-
JP 59181259, 1984; Chem. Abstr. 1985, 102, 113480.
-
(b) JP 59181259, 1984; Chem. Abstr. 1985, 102, 113480.
-
-
-
-
16
-
-
0035088162
-
-
(a) Khan, M. A.; Ellis, G. P.; Pagotto, M. C. J. Heterocycl. Chem. 2001, 38, 193.
-
(2001)
J. Heterocycl. Chem
, vol.38
, pp. 193
-
-
Khan, M.A.1
Ellis, G.P.2
Pagotto, M.C.3
-
17
-
-
0025770299
-
-
(b) Rachedi, Y.; Hamdi, M.; Sakellariou, R.; Speziale, V. Synth. Commun. 1991, 21, 1189.
-
(1991)
Synth. Commun
, vol.21
, pp. 1189
-
-
Rachedi, Y.1
Hamdi, M.2
Sakellariou, R.3
Speziale, V.4
-
18
-
-
0007624750
-
-
(c) Wise, L. D.; Butler, D. E.; DeWald, H. A.; Lustgarten, D. M.; Pattison, I. C.; Schweiss, D. N.; Coughenour, L. L.; Downs, D. A.; Heffner, T. G.; Pugsley, T. A. J. Med. Chem. 1987, 30, 1807.
-
(1987)
J. Med. Chem
, vol.30
, pp. 1807
-
-
Wise, L.D.1
Butler, D.E.2
DeWald, H.A.3
Lustgarten, D.M.4
Pattison, I.C.5
Schweiss, D.N.6
Coughenour, L.L.7
Downs, D.A.8
Heffner, T.G.9
Pugsley, T.A.10
-
21
-
-
0037391624
-
-
(b) Holzer, W.; Hahn, K.; Brehmer, T.; Claramunt, R. M.; Pérez-Torralba, M. Eur. J. Org. Chem. 2003, 1209.
-
(2003)
Eur. J. Org. Chem
, pp. 1209
-
-
Holzer, W.1
Hahn, K.2
Brehmer, T.3
Claramunt, R.M.4
Pérez-Torralba, M.5
-
22
-
-
0005788070
-
-
(a) Sanghvi, Y. S.; Upadhya, K. G.; Dalley, N. K.; Ronibs, R. K.; Revankar, G. R. Nucleosides Nucleotides 1987, 6, 737.
-
(1987)
Nucleosides Nucleotides
, vol.6
, pp. 737
-
-
Sanghvi, Y.S.1
Upadhya, K.G.2
Dalley, N.K.3
Ronibs, R.K.4
Revankar, G.R.5
-
23
-
-
0025283571
-
-
(b) Anderson, J.; Cottam, H. B.; Larson, S. B. J. Heterocycl. Chem. 1989, 27, 439.
-
(1989)
J. Heterocycl. Chem
, vol.27
, pp. 439
-
-
Anderson, J.1
Cottam, H.B.2
Larson, S.B.3
-
24
-
-
42949093268
-
-
Esanu, A. BE 902231, 1985; Chem. Abstr. 1986, 104, 110121.
-
(c) Esanu, A. BE 902231, 1985; Chem. Abstr. 1986, 104, 110121.
-
-
-
-
25
-
-
0014058251
-
-
(a) Alberty, J. E.; Hukki, J.; Laitinen, P.; Myry, J. Arzneim. Forsch. 1967, 17, 214;
-
(1967)
Arzneim. Forsch
, vol.17
, pp. 214
-
-
Alberty, J.E.1
Hukki, J.2
Laitinen, P.3
Myry, J.4
-
26
-
-
42949143244
-
-
Chem. Abstr., 1967, 67, 43734.
-
(1967)
Chem. Abstr
, vol.67
, pp. 43734
-
-
-
27
-
-
2742602953
-
-
(b) Sammour, A.; Raouf, A. A.-E.; Elkasaby, M.; Hassan, M. A. Egypt. J. Chem. 1972, 15, 429.
-
(1972)
Egypt. J. Chem
, vol.15
, pp. 429
-
-
Sammour, A.1
Raouf, A.A.-E.2
Elkasaby, M.3
Hassan, M.A.4
-
28
-
-
0032497637
-
-
Chiba, P.; Holzer, W.; Landau, M.; Bechmann, G.; Lorenz, K.; Plagens, B.; Hitzler, M.; Richter, E.; Ecker, G. J. Med. Chem. 1998, 41, 4001.
-
(1998)
J. Med. Chem
, vol.41
, pp. 4001
-
-
Chiba, P.1
Holzer, W.2
Landau, M.3
Bechmann, G.4
Lorenz, K.5
Plagens, B.6
Hitzler, M.7
Richter, E.8
Ecker, G.9
-
29
-
-
1642450736
-
-
The only other example relevant to epoxide opening is found in the reaction of pyrazolone with the intermediate derived from pyrimidone and epichlorohydrin under basic conditions, possibly proceeded via an epoxide intermediate formed in situ: Krivonogov, V. P, Kozlova, G. G, Sivkova, G. A, Spirikhin, L. V, Abdrakhmanov, I. B, Murinov, Yu. I, Tolstikov, G. A, Chem. 2003, 39, 257
-
The only other example relevant to epoxide opening is found in the reaction of pyrazolone with the intermediate derived from pyrimidone and epichlorohydrin under basic conditions, possibly proceeded via an epoxide intermediate formed in situ: Krivonogov, V. P.; Kozlova, G. G.; Sivkova, G. A.; Spirikhin, L. V.; Abdrakhmanov, I. B.; Murinov, Yu. I.; Tolstikov, G. A. Russ. J. Org. Chem. 2003, 39, 257.
-
-
-
-
31
-
-
42949117442
-
-
The structure of 2 was confirmed based on an alternative synthesis in ca. 10% overall yield (Scheme 2).
-
The structure of 2 was confirmed based on an alternative synthesis in ca. 10% overall yield (Scheme 2).
-
-
-
-
32
-
-
42949176321
-
-
General Procedures for Method A To a stirring suspension of 1 (15.0 g, 49 mmol) in dry MeCN (100 mL) at 0°C was added Mg(ClO 4)2 (33 g, 146 mmol) in 3 portions over 1 min. After the reaction temperature returned to 0°C, the epoxide was added. The flask was equipped with a reflux condenser and was heated for the specified time and temperature. The solution was then concentrated under reduced pressure, dissolved in CHCl3 (100 mL, chilled to 10°C, and quenched with ice-cold water (200 mL, The resulting biphasic solutions were stirred for 1 h and separated. The aqueous layer was extracted with CHCl3 (2 x 50 mL, and the combined organic layers were washed with NH4Cl (sat, dried over MgSO4, and concentrated. The crude product was purified on SiO2 (120 g) chromatography eluting with a gradient of 1-2.5% of MeOH-CH2Cl2. General Procedure for Method B To a sti
-
2 (40 g) chromatography eluting with 25-75% of EtOAc in hexane.
-
-
-
-
33
-
-
42949091998
-
-
All compounds were characterized by 1H NMR and LC-MS to be >95% pure except for 3 that was further derivatized via the mesylate. Selected 1H NMR, 400 MHz, CHCl3-d1, δ in ppm] data are provided for compounds listed in Table 1: Compound 4: 0.95 (d, J, 6.26 Hz, 3 H, 2.65 (s, 3 H, 3.38 (dd, J, 14.87, 1.76 Hz, 1 H, 3.43 (s, 1 H, 3.65 (dd, J, 14.97, 9.88 Hz, 1 H, 3.94-4.05 (m, 1 H, 5.23 (s, 2 H, 7.20-7.39 (m, 5 H) 7.39-7.49 (m, 5 H, Compounds 5 and 6: 0.74 (t, J, 7.43 Hz, 3 H, 1.18-1.37 (m, 2 H, 2.67 (s, 3 H, 3.55 (d, J, 13.30 Hz, 1 H, 3.61-3.77 (m, 2 H, 5.27 (d, J, 3.52 Hz, 2 H, 7.27-7.39 (m, 5 H, 7.41-7.51 (m, 5 H, Compound 7: 2.68 (s, 3 H, 3.21-3.34 (m, 2 H, 3.65-3.78 (m, 1 H, 3.80-3.90 (m, 1 H, 4.02-4.12 (m, 1 H, 5.16-5.31 (m, 2 H, 5.73 (br s, 1 H, 7.28-7.35 (m, 5 H, 7.36-7.51 (m, 5 H, Compound 8: 0.68 d, J
-
1), δ in ppm] data are provided for compounds listed in Table 1: Compound 4: 0.95 (d, J = 6.26 Hz, 3 H), 2.65 (s, 3 H), 3.38 (dd, J = 14.87, 1.76 Hz, 1 H), 3.43 (s, 1 H), 3.65 (dd, J = 14.97, 9.88 Hz, 1 H), 3.94-4.05 (m, 1 H), 5.23 (s, 2 H), 7.20-7.39 (m, 5 H) 7.39-7.49 (m, 5 H). Compounds 5 and 6: 0.74 (t, J = 7.43 Hz, 3 H), 1.18-1.37 (m, 2 H), 2.67 (s, 3 H), 3.55 (d, J = 13.30 Hz, 1 H), 3.61-3.77 (m, 2 H), 5.27 (d, J = 3.52 Hz, 2 H), 7.27-7.39 (m, 5 H), 7.41-7.51 (m, 5 H). Compound 7: 2.68 (s, 3 H), 3.21-3.34 (m, 2 H), 3.65-3.78 (m, 1 H), 3.80-3.90 (m, 1 H), 4.02-4.12 (m, 1 H), 5.16-5.31 (m, 2 H), 5.73 (br s, 1 H), 7.28-7.35 (m, 5 H), 7.36-7.51 (m, 5 H). Compound 8: 0.68 (d, J = 6.85 Hz, 3 H), 0.74 (d, J = 6.85 Hz, 3 H), 1.49 (dd, J = 12.81, 6.75 Hz, 1 H), 2.67 (s, 3 H), 3.25 (br s, 1 H), 3.46-3.53 (m, 1 H), 3.58-3.64 (m, 1 H), 3.70-3.80 (m, 1 H), 5.29 (q, J = 12.78 Hz, 2 H), 7.28-7.41 (m, 6 H), 7.42-7.50 (m, 4 H). Compound 9: 0.95 (s, 6 H), 2.65 (s, 3 H), 3.77 (s, 2 H), 4.79 (s, 1 H), 5.21 (s, 2 H), 7.23 (d, J = 7.43 Hz, 2 H), 7.27-7.33 (m, 1 H), 7.37 (q, J = 7.50 Hz, 3 H), 7.42-7.47 (m, 2 H), 7.50 (t, J = 7.73 Hz, 2 H). Compound 10: 0.74 (t, J = 7.53 Hz, 3 H), 0.82-0.93 (m, 1 H), 1.02 (s, 3 H), 1.23-1.43 (m, 2 H), 2.72 (s, 3 H), 3.68-3.89 (m, 2 H), 5.30-5.33 (m, 2 H), 7.21-7.27 (m, 3 H), 7.29-7.37 (m, 3 H), 7.42-7.53 (m, 4 H). Compound 11: 1.05 (d, J = 6.1 Hz, 3 H), 1.41 (d, J = 7.2 Hz, 3 H), 2.12 (d, J = 3.3 Hz, 1 H), 3.75-3.85 (m, 1 H), 2.70 (s, 3 H), 3.87-3.97 (m, 1 H), 5.29 (s, 2 H), 7.22-7.29 (m, 3 H), 7.29-7.35 (m, 2 H), 7.35-7.42 (m, 1 H), 7.42-7.51 (m, 4 H).
-
-
-
-
35
-
-
33847087192
-
-
3, see: Schreiber, S. L. J. Am. Chem. Soc. 1980, 102, 6163.
-
3, see: Schreiber, S. L. J. Am. Chem. Soc. 1980, 102, 6163.
-
-
-
-
36
-
-
0025277198
-
-
(a) Chini, M.; Croti, P.; Macchia, F. Tetrahedron Lett. 1990, 31, 4661.
-
(1990)
Tetrahedron Lett
, vol.31
, pp. 4661
-
-
Chini, M.1
Croti, P.2
Macchia, F.3
-
37
-
-
0037388155
-
-
(b) Schoffers, E.; Tran, S. D.; Mace, K. Heterocycles 2003, 60, 769.
-
(2003)
Heterocycles
, vol.60
, pp. 769
-
-
Schoffers, E.1
Tran, S.D.2
Mace, K.3
|